Aileron Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol: ALRN on Nasdaq
Industry: Pharmaceutical Preparations
Location: 12407 N. Mopac Expy., Suite 250 #390, Austin, TX

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+400	0.4%	$2.24	+$898
Sells	1	-95.1K	99.6%	$3.86	-$367K
Net	0	-94.7K	-99.2%		-$366K

Aileron Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
University Of Texas/Texas Am Investment Management Co	10%+ Owner	$5.68M	-$367K	-6.08%	Jun 14, 2024
James Brian Windsor	President and CEO	$16.4K	+$898	+5.8%	Dec 5, 2024
Timothy M. Cunningham	Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney				May 16, 2024
Manuel Aivado	Director				Dec 2, 2024
Alan A. Musso	Director				Dec 2, 2024
Charles Garner	Senior Vice President, Finance				Mar 25, 2024
William Fairey	Director				Dec 2, 2024
Reinhard J. Ambros	Director				Dec 2, 2024
Josef H. Von Rickenbach	Director				Dec 2, 2024
Allen Annis	SVP, Research				Mar 30, 2022
Susan L. Drexler	Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney				Jun 15, 2022
Vojo Vukovic	Chief Medical Officer				Mar 30, 2022
Jodie Pope Morrison	Director				Jun 15, 2022
Rick Wanstall	Chief Financial Officer and Treasurer				Mar 30, 2022
Jeffrey A. Bailey	Director				Jun 15, 2021
William Mckee	Director				Jun 15, 2022
Nolan Howard Sigal	Director				Jun 15, 2022

Recent Insider Transactions by Companies or Individuals for Aileron Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.